Abstract
Posterior reversible encephalopathy syndrome (PRES) is a clinical syndrome that manifests with the onset of headache, confusion or decreased level of consciousness, visual changes, and seizures in conjunction with the typical neuroimaging features of posterior cerebral white matter changes, which are usually reversible. This syndrome has been associated with hypertension, eclampsia, renal insufficiency, immunosuppressive drugs, and connective-tissue diseases. To our knowledge, only four cases of PRES associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis have been reported in the literature. Here, we present a patient with ANCA-associated vasculitis complicated by PRES.
References
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494–500
Barttynski WS (2008) Posterior reversible encephalopathy syndrome. Part 2: Controversies surrounding pathophysiology of vasogenic edema. Am J Neuroradiol 29(6):1043–1049
Preston GA, Yang JJ et al (2002) Understanding the pathogenesis of ANCA: where are we today? Cleve Clin J Med 69(2):SII51–SII54
Nishio M, Yoshioka K, Yamagami K, Morikawa T, Konishi Y, Hayashi N, Himuro K, Imanishi M (2008) Reversible posterior leukoencephalopathy syndrome: a possible manifestation of Wegener’s granulomatosis-mediated endothelial injury. Mod Rheumatol 18(3):309–314
Ohta T, Sakano T, Shiotsu M, Furue T, Ohtani H, Kinoshita Y, Mizoue T, Kiya K, Tanaka I (2004) Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol 19(4):442–444
Primavera A, Audenino D, Mavilio N, Cocito L (2001) Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis 60(5):534–537
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fuentes, A.G., Komarla, A. & Gomez, J.I. Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis. Rheumatol Int 32, 2529–2530 (2012). https://doi.org/10.1007/s00296-010-1367-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1367-8